Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo

Coronary Artery Disease

Volumn 21, Issue 5, 2010, Pages 304-311

  Ito, Yoshitaka ^a   Ito, Kenta ^a   Shiroto, Takashi ^a   Tsuburaya, Ryuji ^a   Yi, Gao Jun ^a   Takeda, Morihiko ^a   Fukumoto, Yoshihiro ^a   Yasuda, Satoshi ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

angiogenesis; reperfusion; shock wave; ventricular remodeling

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON CATHETER; CAPILLARY DENSITY; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACORPOREAL LITHOTRIPSY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ANIMAL; CAPILLARY; CORONARY ARTERY BLOOD FLOW; DISEASE MODEL; ECHOCARDIOGRAPHY; ENZYMOLOGY; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; HEART VENTRICLE PRESSURE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; RADIATION; THERAPEUTIC USE; TIME; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CAPILLARIES; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HIGH-ENERGY SHOCK WAVES; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; STROKE VOLUME; SUS SCROFA; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE; VENTRICULAR REMODELING; CARDIAC CATHETERIZATION;

EID: 77954660554     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32833aec62     Document Type: Article

References (42)

1. Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, KiveläA, et al. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 2004; 109:1029-1035.
2. Kastrup J, Jørgensen E, Rück A, Tägil K, Glogar D, Ruzyllo W, et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. A randomized doubleblind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol 2005; 45:982-988.
3. Gupta R, Tongers J, Losordo DW. Human studies of angiogenic gene therapy. Circ Res 2009; 105:724-736.
4. van Ramshorst J, Bax JJ, Beeres SL, Dibbets-Schneider P, Roes SD, Stokkel MP, et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 2009; 301:1997-2004.
5. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364:141-148.
6. Schächinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final 1-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004; 44:1690-1699.
7. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006; 27:2775-2783.
8. Davani S, Deschaseaux F, Chalmers D, Tiberghien P, Kantelip JP. Can stem cells mend a broken heart? Cardiovasc Res 2005; 65:305-316.
9. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemiainduced myocardial dysfunction in pigs in vivo. Circulation 2004; 364:183-192.
10. Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis 2006; 17:63-70.
11. Kikuchi Y, Ito K, Ito Y, Shiroto T, Tsuburaya R, Aizawa K, et al. Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ J 2010; 74:589-591.
12. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, et al. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis 2007; 18:397-404.
13. Klein HH, Schubothe M, Nebendahl K, Kreuzer H. Temporal and spatial development of infarcts in porcine hearts. Basic Res Cardiol 1984; 79:440-447.
14. Pich S, Klein HH, Lindert S, Nebendahl K, Kreuzer H. Cell death in ischemic, reperfused porcine hearts: a histochemical and functional study. Basic Res Cardiol 1988; 83:550-559.
15. Shimokawa H, Ito K, Fukumoto Y, Yasuda S. Extracorporeal cardiac shock wave therapy for ischemic heart disease. Shock Waves 2008; 17:449-455.
16. Ito K, Fukumoto Y, Shimokawa H. Extracorporeal shock wave therapy as a new and non-invasive angiogenic therapy. Tohoku J Exp Med 2009; 219:1-9.
17. Versteilen AM, Korstjens IJ, Musters RJ, Groeneveld AB, Sipkema P. Rho kinase regulates renal blood flow by modulating eNOS activity in ischemiareperfusion of the rat kidney. Am J Physiol Renal Physiol 2006; 291:F606-F611.
18. Oi K, Fukumoto Y, Ito K, Uwatoku T, Abe K, Hizume T, et al. Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits. Tohoku J Exp Med 2008; 214:151-158.
19. Kushner FG, Hand M, Smith SC Jr, King SB III, Anderson JL, Antman EM, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120:2271-2306.
20. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29:2909-2945.
21. Yasuda S, Shimokawa H. Acute myocardial infarction: the enduring challenge for cardiac protection and survival. Circ J 2009; 73:2000-2008.
22. Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, et al. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI registry study. Circ J 2010; 74:93-100.
23. Jessup M, Brozena S. Heart failure. N Engl J Med 2003; 348:2007-2018.
24. Apfel RE. Acoustic cavitation: a possible consequence of biomedical uses of ultrasound. Br J Cancer 1982; 45 (Suppl):140-146.
25. Wang FS, Wang CJ, Huang HJ, Chung H, Chen RF, Yang KD. Physical shock wave mediates membrane hyperpolarization and Ras activation for osteogenesis in human bone marrow stromal cells. Biochem Biophys Res Commun 2001; 287:648-655.
26. Seidl M, Steinbach P, Wörle K, Hofstädter F. Induction of stress fibers and intercellular gaps in human vascular endothelium by shock-waves. Ultrasonics 1994; 32:397-400.
27. Gotte G, Amelio E, Russo S, Marlinghaus E, Musci G, Suzuki H. Short-time non-enzymatic nitric oxide synthesis from L-arginine and hydrogen peroxide induced by shock waves treatment. FEBS Lett 2002; 520:153-155.
28. Mariotto S, Cavalieri E, Amelio E, Ciampa AR, de Prati AC, Marlinghaus E, et al. Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide 2005; 12:89-96. (Pubitemid 40312450)
29. Amano K, Matsubara H, Iba O, Okigaki M, Fujiyama S, Imada T, et al. Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Hypertension 2003; 41:156-162.
30. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101:2567-2578.
31. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 1999; 31:23-37.
32. Millauer B,Wizigmann-Voos S, Schnürch H, Martinez R, Møller NP, RisauW, et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72:835-846.
33. Grunewald M, Avraham I, Dor Y, Bachar-Lusting E, Itin A, Yung S, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006; 124:175-189.
34. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362:697-703.
35. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Lowenergy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006; 114:2823-2830.
36. Yip HK, Chang LT, Sun CK, Youssef AA, Sheu JJ, Wang CJ. Shock wave therapy applied to rat bone marrow-derived mononuclear cells enhances formation of cells stained positive for CD31 and vascular endothelial growth factor. Circ J 2008; 72:150-156.
37. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349:1893-1906.
38. Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G. ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation 1995; 92:3132-3137.
39. Weber KT. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 1997; 96:4065-4082.
40. Ertl G, Frantz S. Healing after myocardial infarction. Cardiovasc Res 2005; 66:22-32.
41. Dohmann HF, Perin EC, Takiya CM, Silva GV, Silva SA, Sousa AL, et al. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation 2005; 112:521-526.
42. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361:45-46.